2 completed, 1 recruiting. 3 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Completed 2, Recruiting 1 |
Follow PCV: new trials by email Literature Review of PCV trials Research Report on PCV
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Clinical Study to Improve Brain Function and Quality of Life of Patients With Newly Diagnosed Brain Tumors (Gliomas). CETEG, PCV, RT - Oligodendroglioma | Phase 3 | Recruiting | University Hospital Heidelberg | 406 | 2021-04-07 | 2026-02-03 |
| A Study to Evaluate the Safety and Immunogenicity of 4 Doses of MenACWY Conjugate Vaccine, Administered Concomitantly With Routine Vaccines, Among Infants Aged 2 Months MenACWY-CRM, DTaP-IPV/Hib, HBV - Meningococcal Disease | Phase 3 | Completed | Novartis Vaccines | 529 | 2009-11-01 | 2014-04-21 |
| Pneumococcal Conjugate Vaccination in HIV in Comparison to Polysaccharide Vaccine Boosting pneumococcal conjugate vaccine, pneumococcal polysaccharide vaccine - HIV Infections, Streptococcus Pneumoniae | Phase 3 | Completed | Henry M. Jackson Foundation for the Advancement of Military Medicine | 275 | 2002-12-01 | 2025-06-08 |
HIV Infections (1) · Meningococcal Infections (1) · Oligodendroglioma (1)
Henry M. Jackson Foundation for the Advancement of Military Medicine (1) · Novartis Vaccines (1) · University Hospital Heidelberg (1)
United States (2) · Australia (1) · Canada (1) · Germany (1)
Brian Agan, MD (1) · Wolfgang Wick, Prof. Dr. (1)
PMID 20795819, PMID 20887830, PMID 35692047
2018 (1)